Anlon Healthcare Limited has announced a board meeting to consider the financial results for the quarter and half-year ending June 30, 2026. The company is also pursuing an acquisition of 32.52% in Apiqo Organics Private Limited and 43.33% in Bizotic LifeScience Private Limited, aiming to make them wholly-owned subsidiaries through...
Company clarified submission of financial results for Q1 FY26. It provided the machine-readable format and covering letter as requested, resolving earlier queries without impacting disclosed figures.
Here's a summary of Anlon Healthcare Limited's financial results: **1. Financial Performance:** Consolidated revenue from operations stood at ₹508.89 Cr for the full year, a significant increase from ₹355.78 Cr in the previous year. This growth was driven by the company's core business of manufacturing and selling Active Pharmaceutical Ingredients...
